Recent studies suggest that the BCR-ABL gene plays a critical role in the pathogenesis of Ph' chronic myeloid leukemia (CML). We investigated the hematopoietic colonies derived from the marrows of 12 patients with Ph' CML in chronic phase by reverse transcriptase-polymerase chain reaction (RT-PCR) amplification of BCR-ABL mRNA and by cytogenetics. Colonies were individually harvested and each colony divided into two portions. one for cytogenetics and the other for isolation of total RNA for PCR of BCR-ABL transcripts and for an RNA internal control. We found that 23% k 18% (mean ? SD, range 0% to 60%) of Ph+ colonies did not transcribe the aberrant gene. In each case when BCR-ABL transcription was not detected, normal ABL mRNA was present.
NCREASING EVIDENCE has accumulated that BCR-ABL plays a pivotal role in the pathogenesis of Ph+ chronic myeloid leukemia (CML)."' It has long been held that expression of BCR-ABL in CML is constitutive and universal for cells exhibiting the Ph translo~ation.~ Most investigations have involved either primary CML cells, comprising mixtures of different lineages, including Ph" populations, or Ph+ leukemic cell lines.'" However, such studies are unable to provide an analysis of aberrant gene transcription in specific CML cell types, including early progenitors.
In particular, an analysis of the expression of BCR-ABL in individual Ph+ progenitors and their more differentiated progeny may provide further insights into the disease, its progression, and may help to account for the considerable heterogeneity in clinical manifestations. Although several investigators have recently manipulated CML marrow or peripheral blood on the basis of immunophenotypic and flow cytometric light scatter properties to better characterize early hematopoietic precursors, the principal purpose has been to isolate nonclona1 primitive Ph- In the present study, we have taken an alternative approach as a first step to investigate the regulation of BCR-ABL in Ph' early precursors and their progeny. Hematopoietic colonies identifying the progenitors CFU-GM, BFU-E, and CFU-GEMM were derived from the marrows of patients with Ph+ CML in chronic phase, and each colony analyzed both by
The data suggest that hitherto unknown mechanisms may regulate BCR-ABL expression in some Ph' cells and indicate that caution should be exercised in the interpretation of results using RT-PCR analysis of hematopoietic colonies from clinical specimens and from experiments with antisense oligonucleotides directed at the BCR-ABL gene. These data also raise the notion of a transitional Ph' precursor cell in which BCR-ABL may become upregulated and lead to a fully expressed phenotype. We conclude that further studies correlating the frequency of Ph' PCR-progenitors with prognostic clinical variables are warranted. 0 1994 by The American Society of Hematofogy.
cytogenetics"' and by reverse transcriptase-polymerase chain reaction (RT-PCR) amplification of BCR-ABL mRNA."
PATIENTS AND METHODS
Bone marrow (BM) aspirates from 12 patients with Ph' CML and normal BM donors were obtained according to local institutional review board-approved protocols. Clinical features of the patients are outlined in Table 1 . All were in chronic phase at the time of investigation and all had cells that were entirely Ph' by routine cytogenetic analysis (25 metaphases), except for patient 6 on ainterferon therapy who had 23 Ph' and three normal metaphases.
Marrow mononuclear cells were obtained by density gradient centrifugation as previously published." EM-2, a permanent Ph' myeloid leukemia cell line,".I4 was used as a positive control for detection of BCR-ABL mRNA. The cells were maintained in RPM1 (GIBCO, Grand Island, NY) with 5% fetal bovine serum in the log phase of cell growth at 2 to 5 X 105/mL.
Hematopoietic colonies. The schema for the analysis of Ph' colonies is outlined in Fig 1. Colonies were generated in methylcellulose according to an established method'* and individually harvested from dishes 10 to 12 days (patients l through 10) and 7 to 10 days (patients 11 and 12) after culture initiation using a micropipette and an inverted microscope. Each colony was suspended in a separate microcentrifuge tube containing phosphate-buffered saline. Experiments were conducted with erythroid/multilineage colonies and with granulocytic colonies. For patients 1 through 10 the colonies comprised 50 to 250 cells, but every effort was made to isolate and analyze colonies of a similar size, approximately 100 cells per colony for a given experiment. In the case of patients l1 and 12, larger colonies of up to 500 cells were analyzed earlier after culture initia- The cells were then fixed by gently dropping 0.1 mL cold fixative onto the slide, the excess hypotonic solution removed with absorbent paper, and the slides dried on a hot plate at 55°C. After repeat cold fixation for 15 minutes, the cells were ready for banding and cytogenetic analysis.
In general, 30 colonies were screened to yield 20 colonies that were informative by cytogenetic analysis and included a minimum of four adequate metaphases per colony portion.
Detection of BCR-ABL mRNA in colony cells by RT-PCR. After removal of cells for cytogenetics, RNA was prepared from the remainder of the colony as follows. Cells were resuspended in isotonic high pH buffer (140 mmoVL NaCl, 10 mmoliL Tris-Cl, 1.5 mmoY L MgClz, pH 8.0) containing 0.5% NP-40 and 0.01% fresh diethylpyrocarbonate (DEP) (from a stock solution of 10% DEP in ethanol).
Cells were vortexed, nuclei pelleted for 10 seconds in a microcentrifuge, and the supernatant transferred to a microcentrifuge tube in a humidified water bath at 37°C for 20 minutes, then in a humidified water bath at 90°C for a further 15 to 20 minutes.
Total RNA from each colony was divided into two parts, one for BCR-ABL mRNA by RT-PCR and the other to establish RNA integrity by testing for normal ABL sequence transcription. RT-PCR was performed by a modification of a previously published method." 
GCATGGCCTTCAGGGTGCACAGCCGCAACGGCAA-3'
CCTCTGACTATGAGCGTGCA-3' [BCR -250 to -2201 and 5"TCAGACCCTGAGGCTCAAAGTC-3', ABL: 5"CAGCGGC-CAGTAGCATCTGACTT-3' [ABL +9 to +31] and 5"TCACTG-GGTCCAGCGAGAAGGTT'ITCCTTGGAGIT-3') with 50 pL of reaction mixture containing 3 pL of first-round products as the template for an additional 30 cycles. PCR products were separated electrophoretically through 3% NuSieve (FMC Bioproducts, Rockland, MEl)-l% Sea Kem ME agarose gel and visualized by ethidium bromide fluorescence. Samples were also blotted onto nylon filters and hybridized to "P end-labeled antisense oligonucleotides spanning the bcr3-ab12 or bcr2-ab12 junction (5"GCTGAAGGGCTmG-3', respectively).
RNA dot blots. RNA dot blots were performed according to a standard method.16 RNA preparations isolated from CML mononuclear cells, normal donor marrow mononuclear cells, and EM-2 cells were probed with "P end-labeled oligonucleotide spanning the bcr3-ab12 junction (5'-GCTGAAGGGCTTITGAACCTCTGCT-3'). The cDNA probe was derived from a 299-bp PCR product generated from EM-2 RNA using oligonucleotides that flank the bcr3-ab12 junction as described above. The probe was prepared in large scale using the cloning strategy described in the T-A Cloning Instruction manual from Invitrogen Corp (San Diego, CA). The correct sequence was confirmed by DNA sequencing using the standard dideoxy method. For the RNA control, blots were reprobed with a 1.8-kb p- For cells per colony) were Ph' and positive for BCR-ABL mRNA by RT-PCR (n = 100). The method was also highly specific because all multilineage colonies derived from normal donor marrow were negative by PCR (n = 100).
In the first series of experiments, erythroid and multilineage colonies were individually and separately analyzed at day IO to 12 after culture initiation for the presence of BCR-ABL transcripts and for the Ph chromosome, as shown in Table 2 (patients 1 and 2) .
Subsequent experiments (patients 3 through 12) confirmed the discordance between cytogenetic and PCR analyses when individual colonies were divided into two portions according to the schema in Fig 1. Colony portions were informative by cytogenetics only if at least four Ph' metaphases were documented in each portion. Whenever this was encountered, normal metaphases were always absent. PCR-generated products were visualized by ethidium bromide fluorescence and by DNA hybridization with radiolabeled oligonucleotide probes encompassing the bcr3-ab12 and hcr2-ah12 junctions. Figure 2 shows representative ethidium bromide staining of BCR-ABL RT-PCR products from portions of Ph' colonies derived from the marrow of patient IO. In each case where BCR-ABL transcription was not detected, normal ABL mRNA was present, excluding trivial technical reasons for the failure to detect specific mRNAs from colony cells.
Results were not influenced by colony type. When data from all evaluable granulopoietic and early erythroid colonies derived from the 12 patients are combined, the frequency of Ph' BCR-ABL transcript(-) colonies is similar for BFU-E and CFU-GM: 14/71 (20%) and 19/83 (23%), respectively. In addition, a direct comparison of multilineage and erythroid colonies with granulopoietic colonies in patients l l and 12 shows similar results ( Table 3) .
Variations in colony size on the ability to PCR amplify BCR-ABL cDNA were also investigated. Results with RT-PCR of whole colonies derived from the marrows of patients 1 and 2 were the same when divided colonies were analyzed. Moreover, colonies of a similar size (approximately 100 cells) were analyzed from cultures generated from patients 3 through IO. Larger colonies of similar size were also ana- 
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..*@* lyzed (patients 1 1 and 12) and provided results within the range detected for smaller colony portions (Table 3) . Finally, PCR analysis of serially diluted lysates from portions of two colonies (one erythroid, one multilineage) of approximately 500 cells each was performed. Both colonies were Ph' by cytogenetic analysis and were derived from a marrow previously shown to generate Ph' colonies that invariably yielded a detectable BCR-ABL RT-PCR signal. BCR-ABL and ABL control RT-PCR signals remained detectable at a dilution equivalent to 6 colony cells (the lowest dilution tested).
The data in Table 2 show heterogeneity among patients with Ph' CML with respect to the frequency of Ph' hematopoietic colonies that do not transcribe BCR-ABL. Analysis of the marrows from the 12 patients studied indicates that 23% f 18% (mean t SD; range 0% to 60%) had hematopoietic colonies whose Ph' cells had a transcriptionally inactive BCR-ABL gene.
The lack of BCR-ABL transcription in the progeny of some CML precursors could conceivably be related to the artificial conditions imposed on the hematopoietic colony assay. To rule out this possibility, nucleated cell fractions from the marrows of patients studied with colony assays were analyzed for the presence of BCR-ABL transcripts by RNA dot blots.'h In each case, Ph-metaphases were absent in colony cells and in direct preparations of marrow cells. As shown in Fig 3. the intensity of the BCR-ABL RNA dot-blot signal correlated with the frequency of Ph' BCR-ABL transcriptnegative colonies. This is best illustrated by results from patient 9 in whom 60% of Ph+ colonies did not express BCR-ABL transcripts. The dot blot shows markedly reduced BCR-ABL mRNA compared with actin mRNA (Fig 3a and  b. row C) . In contrast, no such reduction in the BCR-ABU &actin mRNA ratio was documented for patient 8 in whom all Ph' colonies transcribed BCR-ABL (Fig 3a and b,  row A) .
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DISCUSSION
Because BCR-ABL appears to be intimately involved in the pathogenesis of CML, further insights into the disease may be gained by a study of the expression of this gene in early hematopoietic precursors.' Our approach to address this issue was to look for the aberrant transcript in cells comprising colonies derived from granulopoietic, erythroid, and multilineage progenitors present in Ph' CML marrow.
The colonies were harvested and individually analyzed for BCR-ABL mRNA using RT-PCR with two sets of internal nested oligonucleotide primers, as well as for the presence of the Ph chromosome by cytogenetic analysis. The protocol involved dividing each colony into two portions, one for cytogenetic analysis and the other to obtain total RNA for PCR to detect BCR-ABL transcripts as well as to confirm integrity of the RNA.
We showed that while being Ph' by cytogenetic analysis, the cells of many such colonies do not contain detectable levels of BCR-ABL mRNA as determined by a sensitive RT-PCR method. Indeed, analysis of Ph+ hematopoietic colonies derived from the marrows of 12 patients with CML in chronic phase indicates that a mean of 23.0% t 18% (tSD)
were Ph' and negative for BCR-ABL mRNA by PCR. Considerable heterogeneity was exhibited by marrows from different patients. For example, marrows derived from two patients generated no Ph' PCR-colonies (ie, all Ph' colonies were also PCR'). In contrast, the marrow of another patient yielded Ph' colonies that were 60% PCR-.
Several lines of evidence indicate that the results are not due to trivial reasons and specifically excludes the possibility that small numbers of cells in colony portions account for the data. The most compelling experiments indicate that in Ph+ colonies prospectively identified as PCR', the PCR signal remains detectable at the lowest dilution tested, a level equivalent to 6 Ph' cells, a number well below that present For personal use only. on October 3, 2017. by guest www.bloodjournal.org From in the smallest colony portions examined. Indeed, our PCR methodology" is of sufficient sensitivity to detect BCR-ABL mRNA in 10 pg of total RNA, suggesting that one BCR-ABL-expressing cell could be identified in a colony portion.
Differences in the PCR signal are not attributable to differences in cell lineage or to the degree of differentiation of cells within colonies because results were not influenced by colony type. Lack of BCR-ABL transcription cannot be attributed to low levels of expression in terminally differentiated neutrophils, because similar frequencies of Ph' PCRcolonies are found when assaying early erythroid as well as granulopoietic progenitors. In addition, GM colonies analyzed earlier after culture initiation (at days 7 through 10, from patients l 1 and 12) and expected to contain fewer differentiated cells, gave similar results. These data infer that the level of BCR-ABL expression in the progeny of CFU-GM is unlikely to account for the predominantly granulocytic phenotype of Ph' CML.
To rule out the possibility that our observations are dependent on the specific conditions imposed by the in vitro colony assay, RNA dot blots of marrow cells were performed. We showed a correlation between BCR-ABL mRNA levels in nucleated marrow cells and the frequency of Ph+ PCR-progenitors in the same marrows, suggesting that the progeny of Ph+ PCR-precursor cells in vivo also do not transcribe the gene.
In a recent study, Bedi et aly showed the presence of a primitive population of CML cells identified by counterflow centrifugal elutriation characteristics and with the CD34' lin-phenotype that did not transcribe BCR-ABL. Interestingly, in response to a combination of c-kif ligand, interleukin-3 (IL-3), and IL-6, such cells generated progeny in liquid culture that transcribed BCR-ABL and expressed the P210 protein, suggesting a differential expression of BCR-ABL in early and more mature Ph' progenitor cells. However, it is possible that the expansion of transcriptionally active BCR-ABL+ late progenitors and more mature cells may be the specific consequence of cytokine stimulation.
The observations of transcriptionally silent Ph' early precursors as shown by Bedi et al, and our data showing similar results in cells comprising hematopoietic colonies, suggest that the mechanism of downregulation of BCR-ABL can be transmitted from early to mature CML cells. This also argues against the notion that transcriptional inactivity of BCR-ABL is confined to early progenitors in Go because many colony cells are actively dividing. Indeed, our methodology specifically selects for colonies containing cells capable of entering metaphase. It would be of interest to determine if similar results are obtained with interphase colony cells identified as Ph' by in situ hybridization."
Our data also suggest that in some Ph* cells, the BCR-ABL gene is under the control of hitherto unknown regulatory mechanisms governing transcription. Such mechanism(s) are operative early (patient 2) and late (patient 7) in the course of the disease (Table l) and do not appear to be dependent on the effects of conventional therapy because untreated or briefly treated subjects (patients 2 and 10) also have transcriptionally suppressed BCR-ABL in Ph+ colony cells.
In this small series there is no obvious correlation between the frequency of Ph+ PCR-colonies and known prognostic factors in CML. However, prospective studies with a larger number of subjects are required to address this issue.
Our observations indicate that RT-PCR is both highly sensitive and very specific for transcription of the BCR-ABL gene in hematopoietic colonies but is less sensitive than cytogenetics in identifying dividing cells with the Ph chromosome. This suggests that data generated by PCR analysis of hematopoietic colonies should be interpreted with caution. Moreover, experiments conducted with antisense oligonucleotides for the purpose of eliminating Ph' cells"*" must overcome the difficulty of targeting Ph' cells in which BCR-ABL is already downregulated. Consequently, methodologies must be used that identify not only the gene product but also the gene in the target cell population.
Finally, the data raise the notion of a Ph+ progenitor cell that is transitional in nature. It is interesting to speculate that Ph' CML precursors may be susceptible to either transcriptional activation or suppression of BCR-ABL. Thus, progenitors with downregulated BCR-ABL may become transcriptionally activated and express the full phenotype of the CML precursor. Alternatively, when BCR-ABL is downregulated (the principal aim of antisense oligonucleotide therapy), such progenitors might lack the proliferative advantage of their transcriptionally active counterparts and may be preferentially eliminated.
It is possible that this experimental system may provide a suitable model for investigating disease progression in CML. Because our findings have clinical implications, additional studies are warranted that identify circumstances leading to increased downregulation of BCR-ABL in Ph+ precursors.
